SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-210740
Filing Date
2023-08-11
Accepted
2023-08-11 16:15:50
Documents
3
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A d495433ddef14a.htm DEF 14A 685466
2 GRAPHIC g495433g17m00.jpg GRAPHIC 249161
3 GRAPHIC g495433g18m00.jpg GRAPHIC 202743
  Complete submission text file 0001193125-23-210740.txt   1309071
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41403 | Film No.: 231164314
SIC: 2834 Pharmaceutical Preparations